In vitro activities of tigecycline against clinical isolates from Shanghai, China

Diagnostic Microbiology and Infectious Disease

Volumn 50, Issue 4, 2004, Pages 267-281

  Zhang, Ying Yuan ^a   Zhou, Le ^a   Zhu, De Mei ^a   Wu, Pei Cheng ^a   Hu, Fu Pin ^a   Wu, Wei Hong ^a   Wang, Fu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Antibiotics; Minimum inhibitory concentration; Susceptibility testing; Tigecycline

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; CEFUROXIME; CHLORAMPHENICOL; CILASTATIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; MINOCYCLINE; OXACILLIN; PENICILLIN G; PIPERACILLIN; SPECTINOMYCIN; SULBACTAM; SULFAMETHOXAZOLE; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ACINETOBACTER BAUMANNII; AEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG SCREENING; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HEMOCONCENTRATION; HOSPITAL; IN VITRO STUDY; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NEISSERIA GONORRHOEAE; NONHUMAN; PEPTOCOCCUS; PH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERUM; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; TIME;

ANTI-BACTERIAL AGENTS; BACTERIA; CHINA; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 9944239338     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.08.007     Document Type: Article

References (15)

1. th edition:1996;52 William & Wilkins Co, London
2. Babini G.S., Livermore D.M. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother. 45:2000;183-189
3. Betriu C., Rodriguez-Avial I., Sanchez B.A., Gomez M., Alvarez J., Picazo J.J. Spanish Group of Tigecycline. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob Agents Chemother. 46:2002;892-895
4. Biedenbach D.J., Beach M.L., Jones R.N. In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum β-lactamases. Diagn Microbiol Infect Dis. 40:2001;173-177
5. Boucher H.W., Wennersten C.B., Eliopoulos G.M. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrob Agents Chemother. 44:2000;2225-2229
6. Dai Z., Liu D., Zhang Y., Liu Y., Wang F. Laboratory evaluation of tetracyclines. Antibiotics. 7:1982;288-294
7. Gales A.C., Jones R.N. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1203 recent clinical bacterial isolates. Diagn Microbiol Infect Dis. 36:2000;19-36
8. Goldstein E.J., Citron D.M., Merriam C.V., Warren Y., Tyrrell K. Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens. Antimicrob Agents Chemother. 44:2000;2747-2751
9. Hoellman D.B., Pankuch G.A., Jacobs M.R., Appelbaum P.C. Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and resistant pneumococci. Antimicrob Agents Chemother. 44:2000;1085-1088
10. Levy S.B. Evolution and spread of tetracycline resistance determinants. J Antimicrob Chemother. 24:1989;1-3
11. Milatovic D., Schmitz F.J., Verhoef J., Fluit A.C. Activities of the glycylcycline tigecycline (GAR-936) against 1924 recent European clinical bacterial isolates. Antimicrob Agents Chemother. 47:2003;400-404
12. Moellering R.C. Problems with antimicrobial resistance in gram-positive cocci. Clin Infect Dis. 26:1998;1177-1178
13. National Committee for Clinical Laboratory Standards (2001). Antimicrobial susceptibility testing standard M7-A5-MIC testing. NCCLS, Villanova, PA.
14. Petersen P.J., Bradford P.A., Weiss W.J., Murphy T.M., Sum P.E., Projan S.J. In vitro and in vivo activities of Tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens. Antimicrob Agents Chemother. 46:2002;2595-2601
15. Speer B.S., Shoemaker N.B., Salyers A.A. Bacterial resistance to tetracyclines mechanisms, transfer, and clinical significance. Clin Microbiol Rev. 5:1992;387-399